Sale of 4,384 shares at $87.11 per share.
Reporting Person Burrows Scott L · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001636282-26-000109 · filed 2026-09-03 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Spyre Therapeutics, Inc. (SYRE)." Disclosed 2026-09-03. https://desqlong.com/cards/0001636282-26-000109-3 (retrieved 2026-09-26).